Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Labcyte BLOG

What Science Can Do – Labcyte and AstraZeneca
MONDAY, AUGUST 29, 2016
linkedin twitter facebook |  56Shares
Our partners at AstraZeneca have a nice profile on their website that talks about our collaboration to create an acoustically loaded mass spec platform, and why they chose to invest in the Labcyte Echo technology. The goal of this work is to expand the utility of mass spectrometry for high-throughput, low-cost, label-free analysis. As you may recall, this product won the SLAS Innovation Award in 2015!

The platform, which generates data at a rate of 10,000 data points per hour, allows AZ to work at very high throughput and with very small sample volumes. Because it only requires 2µl of sample, the company can screen more compounds or more targets for the same cost – sometimes reducing the cost of HTS by 80%.

Jonathan Wingfield, Principal Scientist, Discovery Sciences at AZ commented: “When you see the droplets flying and you see the science behind it – it’s astonishingly cool. It’s revolutionary.”

His 2015 SLAS presentation, “Novel Acoustic Loading of a Mass Spectrometer — Towards Next Generation High Throughput MS Screening,” was what led to the Innovation Award, and the society received so many requests for access to this presentation that they made it freely available for 2 years. You can watch it here. There is also a peer-reviewed paper from the SLAS journal, Journal of Laboratory Automation, available here (open access).

In the AZ article, Dr. Wingfield discusses how and why AZ entered into this project, and what the reaction from the scientific community has been. You can read it here.